<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 15, 1997
REGISTRATION NO. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
-------------------
PEDIATRIX MEDICAL GROUP, INC.
-------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
FLORIDA 65-0271219
------------------------------- ----------------------
(STATE OR OTHER JURISDICTION OF (IRS EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
1455 NORTH PARK DRIVE
FORT LAUDERDALE, FLORIDA 33326
-------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
PEDIATRIX MEDICAL GROUP, INC. AMENDED AND RESTATED STOCK OPTION PLAN
- --------------------------------------------------------------------------------
(FULL TITLE OF THE PLAN)
-------------------
ROGER J. MEDEL, M.D.
PRESIDENT AND CHIEF EXECUTIVE OFFICER
PEDIATRIX MEDICAL GROUP, INC.
1455 NORTH PARK DRIVE
FORT LAUDERDALE, FLORIDA 33326
---------------------------------------------------
(NAME AND ADDRESS OF AGENT FOR SERVICE)
(954) 384-0175
---------------------------------------------------
(TELEPHONE NUMBER, INCLUDING AREA CODE, OF AGENT FOR SERVICE)
COPY TO:
Rebecca R. Orand, Esq.
Greenberg, Traurig, Hoffman,
Lipoff, Rosen & Quentel, P.A.
1221 Brickell Avenue
Miami, Florida 33131
(305) 579-0557
-------------------
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
=================================================================================================================
PROPOSED MAXIMUM PROPOSED
TITLE OF SECURITIES AMOUNT TO BE OFFERING PRICE MAXIMUM AGGREGATE AMOUNT OF
TO BE REGISTERED REGISTERED PER SHARE (1) OFFERING PRICE(1) REGISTRATION FEE
- -----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
COMMON STOCK,
$.01 PAR VALUE.................. 750,000 SHARES $29.00 - $44.78 $26,269,740 $7,968
=================================================================================================================
</TABLE>
(1) Estimated solely for the purpose of calculating the registration fee and
computed in accordance with Rule 457(h) of the Securities Act of 1933, as
amended, on the basis of (i) the actual price of (a) $40.375 for an
aggregate of 60,000 options, and (b) $29.00 for an aggregate of 446,636
options, to purchase Common Stock being registered, which have already
been granted under the Company's Amended and Restated Stock Option Plan,
and (ii) the average of the high and low sale price ($44.78) of the Common
Stock on October 9, 1997 with respect to the 243,364 shares of Common
Stock subject to future grants under the Amended and Restated Stock Option
Plan.
Page 1 of 4 Pages
Exhibit Index at Page II-4
<PAGE> 2
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
The following documents filed with the Securities and Exchange Commission
(the "Commission") by the Registrant are hereby incorporated by reference in
this Registration Statement:
The Registrant hereby incorporates by reference into this Registration
Statement the following documents or portions thereof as indicated:
(a) the Registrant's Registration Statement on Form S-8 (Registration
No. 33-97672), filed with the Commission on October 3, 1995;(1)
(b) the Registrant's Registration Statement on Form S-8 (Registration
No. 333-07057);(2)
(c) the Registrant's Annual Report on Form 10-K for the fiscal year
ended December 31, 1996;
(d) the Registrant's quarterly report on Form 10-Q (i) for the three
months ended March 31, 1997, (ii) for the six months ended June
30, 1997, and all other reports filed by the Registrant pursuant
to Section 13(a) or 15(d) of the Exchange Act since January 1,
1997; and
(e) the description of the Registrant's Common Stock filed as a part
of the Registrant's Registration Statement, as amended, on Form
S-1 under the Securities Act of 1933 (Registration No. 33-95086).
In addition, all documents subsequently filed by the Registrant pursuant
to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing
of a post-effective amendment which indicates that all securities offered hereby
have been sold or which deregisters all securities then remaining unsold, shall
be deemed to be incorporated herein by reference and to be a part hereof from
the date of filing of such documents.
- ----------------------------
1 The Registration Statement on Form S-8 (Registration No. 33-97672), filed
with the Commission on October 3, 1995 (the "Original S-8"), registered
1,500,000 shares of the Registrant's Common Stock.
2 At the Company's 1996 annual meeting of shareholders, held on May 8, 1996,
the Company's shareholders approved an amendment to the Plan, which
increased by 1,000,000 the number of shares available for grant under the
Plan from 1,500,000 to 2,500,000. The Registration Statement on Form S-8,
(Registration No. 33-07057) filed on June 28, 1996, registered the
additional 1,000,000 shares; thus, the total number of shares registered
on Form S-8 and available for grant under the Plan was 2,500,000. At the
Company's 1997 annual meeting of shareholders, held on May 8, 1997, the
Company's shareholders approved an amendment to the Plan, which increased
by 750,000 the number of shares eligible for grant under the Plan from
2,500,000 to 3,250,000. After giving effect to the amendment to the Plan
approved by the Registrant's shareholders at the Company's annual meeting,
and the effectiveness of this Registration Statement on Form S-8, the
total number of shares registered on Form S-8 and available for grant
under the Plan will be 3,250,000.
II-2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Fort Lauderdale, State of Florida on
October 14, 1997.
PEDIATRIX MEDICAL GROUP, INC.
By:/s/ Roger J. Medel, M.D., M.B.A.
---------------------------------------
Roger J. Medel, M.D., M.B.A.
President and Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below hereby constitutes and appoints Roger J. Medel, M.D., M.B.A. and Lawrence
M. Mullen his true and lawful attorneys-in-fact, each acting alone, with full
powers of substitution and resubstitution, for him and in his name, place and
stead, in any and all capacities, to sign any or all amendments, including any
post-effective amendments, to this Registration Statement, and to file the same,
with exhibits thereto, and other documents to be filed in connection therewith,
with the Securities and Exchange Commission, hereby ratifying and confirming all
that said attorneys-in-fact or their substitutes, each acting alone, may
lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/Roger J. Medel, M.D., M.B.A. President, Chief Executive October 14, 1997
- ---------------------------------------- Officer and Director
Roger J. Medel, M.D., M.B.A. (principal executive officer)
/s/M. Douglas Cunningham, M.D. Chief Medical Officer October 14, 1997
- ---------------------------------------- and Director
M. Douglas Cunningham, M.D.
/s/Lawrence M. Mullen Vice President and Chief October 14, 1997
- ---------------------------------------- Financial Officer (principal
Lawrence M. Mullen financial and accounting officer)
/s/Cesar L. Alvarez Director October 14, 1997
- ----------------------------------------
Cesar L. Alvarez
/s/Michael B. Fernandez Director October 14, 1997
- ----------------------------------------
Michael B. Fernandez
/s/Albert H. Nahmad Director October 14, 1997
- ----------------------------------------
Albert H. Nahmad
/s/Bruce R. Evans Director October 14, 1997
- ----------------------------------------
Bruce R. Evans
/s/E. Roe Stamps, IV Director October 14, 1997
- ----------------------------------------
E. Roe Stamps, IV
</TABLE>
II-3
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT SEQUENTIAL
NUMBER DESCRIPTION PAGE NO.
------ ----------- --------
<S> <C> <C>
4.1 Registrant's Amended and Restated
Articles of Incorporation(1)
4.2 Registrant's Amended and Restated
Bylaws(2)
4.3 Pediatrix Medical Group, Inc. Amended
and Restated Stock Option Plan, as
amended(3)
5.1 Opinion of Greenberg, Traurig, Hoffman,
Lipoff, Rosen & Quentel, P.A.
23.1 Consent of Coopers & Lybrand L.L.P.
23.2 Consent of Greenberg, Traurig, Hoffman,
Lipoff, Rosen & Quentel, P.A. (contained
in its opinion filed as Exhibit 5.1
hereto)
24.1 Power of Attorney is included in the
Signatures section of this Registration
Statement
</TABLE>
- ----------------------
(1) Incorporated by reference to Exhibit 3.1 filed with the Registrant's
Registration Statement on Form S-1 (Registration No. 33-95086).
(2) Incorporated by reference to Exhibit 3.2 filed with the Registrant's
Registration Statement on Form S-1 (Registration No. 33-95086).
(3) Incorporated by reference to Exhibit A filed with the Registrant's
Schedule 14A filed on April 4, 1997.
II-4
<PAGE> 1
EXHIBIT 5.1
October 14, 1997
Pediatrix Medical Group, Inc.
1455 North Park Drive
Fort Lauderdale, Florida 33326
Re: Registration Statement on Form S-8
Ladies and Gentlemen:
On the date hereof, Pediatrix Medical Group, Inc., a Florida corporation
(the "Company"), sent for filing with the Securities and Exchange Commission a
Registration Statement on Form S-8 (the "Registration Statement"), under the
Securities Act of 1933, as amended (the "Act"). The Registration Statement
relates to the offering and sale by the Company of up to 750,000 shares of the
Company's Common Stock, par value $.01 per share (the "Common Stock"), pursuant
to stock options ("Options") granted or to be granted under the Company's
Amended and Restated Stock Option Plan, as amended (the "Plan"). We have acted
as special counsel to the Company in connection with the preparation and filing
of the Registration Statement.
In connection therewith, we have examined and relied upon the original or
a copy, certified to our satisfaction, of (i) the Amended and Restated Articles
of Incorporation and Bylaws of the Company; (ii) records of corporate
proceedings of the Company, authorizing the Plan, any amendments thereto, and
the preparation of the Registration Statement and related matters; (iii) the
Registration Statement and exhibits thereto; and (iv) such other documents and
instruments as we have deemed necessary for the expression of the opinions
herein contained. In making the foregoing examinations, we have assumed the
genuineness of all signatures and the authenticity of all documents submitted to
us as originals, and the conformity to original documents of all documents
submitted to us as certified or photostatic copies. As to various questions of
fact material to this opinion, we have relied, to the extent we deem reasonably
appropriate, upon representations or certificates of officers or directors of
the Company and upon documents, records and instruments furnished to us by the
Company, without independently checking or verifying the accuracy of such
documents, records and instruments.
Based upon the foregoing examination, we are of the opinion that the
Company presently has available at least 750,000 authorized and unissued shares
of Common Stock from which the 750,000 shares of Common Stock proposed to be
sold pursuant to the exercise of Options granted under the Plan may be issued,
and, assuming that the Company maintains an adequate number of authorized and
unissued shares of Common Stock available for issuance to those persons who
exercise Options granted under the Plan and the consideration for shares of
Common Stock issued pursuant to such Options is actually received by the Company
as provided in the Plan, the shares of Common Stock issued pursuant to the
exercise of Options granted under and in accordance with the terms of the Plan
will be duly and validly issued, fully paid and nonassessable.
<PAGE> 1
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to the incorporation by reference in the registration statement of
Pediatrix Medical Group, Inc. on Form S-8 of our report dated January 27, 1997,
except as to information presented in Note 14, for which the date is March 26,
1997, on our audits of the consolidated financial statements and financial
statement schedule of Pediatrix Medical Group, Inc., as of December 31, 1996 and
1995, and for the years ended December 31, 1996, 1995 and 1994 which report is
included in the Annual Report on Form 10-K.
COOPERS & LYBRAND L.L.P.
Fort Lauderdale, Florida
October 14, 1997
